normalmente disponibile
per la spedizione in 10-15 giorni lavorativi
da
a
€ 182,78
DESCRIZIONE
Learn to implement effective control measures for mutagenic impurities in pharmaceutical development In Mutagenic Impurities: Strategies for Identification and Control, distinguished chemist Andrew Teasdale delivers a thorough examination of mutagenic impurities and their impact on the pharmaceutical industry. The book incorporates the adoption of the ICH M7 guideline and focuses on mutagenic impurities from both a toxicological and analytical perspective. The editor has created a primary reference for any professional or student studying or working with mutagenic impurities and offers readers a definitive narrative of applicable guidelines and practical, tested solutions. It demonstrates the development of effective control measures, including chapters on the purge tool for risk assessment. The book incorporates a discussion of N-Nitrosamines which was arguably the largest mutagenic impurity issue ever faced by the pharmaceutical industry, resulting in the recall of Zantac and similar drugs resulting from N-Nitrosamine contamination. Readers will also benefit from the inclusion of: Perfect for chemists, analysts, and regulatory professionals, Mutagenic Impurities: Strategies for Identification and Control will also earn a place in the libraries of toxicologists and clinical safety scientists seeking a one-stop reference on the subject of mutagenic impurity identification and control.
DETTAGLI PRODOTTO torna su
ISBN: 9781119551218
Titolo: Mutagenic Impurities : Strategies for Identification and Control
Autori: Teasdale
Editore: Wiley
Volume: Unico
Edizione: 2022
Lingua: Inglese
Finitura: Copertina rigida
Pagine: 512
RECENSIONI
NESSUNA RECENSIONE PER QUESTO PRODOTTO